Propensity Matching Is a Poor Substitute for a Poorly Composed Procedure Note⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.  by Jones, Robert H.
Journal of the American College of Cardiology Vol. 61, No. 3, 2013
© 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.09.047EDITORIAL COMMENT
Propensity Matching Is a
Poor Substitute for a Poorly
Composed Procedure Note*
Robert H. Jones, MD
Durham, North Carolina
Internal thoracic artery (ITA) use played a prominent role
in the development of surgical treatments for coronary
artery disease (1). In 1935, Claude S. Beck sutured a pedicle
containing internal mammary vessels onto the anterior heart
wall of a 48-year-old gardener who 7 months later returned
to work without future pain (2). In 1967, Kolessov, a
Russian cardiac surgeon, reported the first successful use of
the left ITA in 6 patients without preoperative coronary
angiography. A left thoracotomy permitted palpation to
identify a non-calcific zone of the left anterior descending
(LAD) coronary artery in each patient to which an end-to-
side anastomosis of the ITA was made. Five of the 6
patients survived (3).
See page 302
News of these successful first direct ITA to coronary
artery bypass operations prompted Favaloro to use saphe-
nous vein to construct an ascending aorta to right coronary
artery anastomosis in 1967 (4). Dr. George Green (5)
described his careful experimental work with ITA to LAD
bypass grafts in dogs and reported 2 patients operated on
February 29 and March 12, 1968, who received an ITA to
LAD operation without need for clamping the aorta. Dr.
Green emphasized the need for optical magnification to
precisely construct the ITA to coronary anastomosis.
Given the choice between an operation that could be
done using venous conduit with hemodynamic support of
cardiopulmonary bypass for an arrested heart or use of a
small delicate ITA coronary bypass on a beating heart, it is
not surprising that an ITA to LAD was not the coronary
bypass procedure of choice of the CASS (Coronary Artery
Surgical Study) trial investigators. Although use of artery or
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protocol, only 16% of patients randomized to the surgical
arm of the CASS trial between August 1975 and May 1979
received an ITA bypass to the LAD coronary artery (6).
Leading cardiac surgeons of that era were not convinced
ITA use added value to coronary artery bypass grafting
(CABG).
The minority of cardiac surgeons who continued to
champion ITA use were those who had observed gradual
development of collateral blood flow using the Vineberg
modification of the Beck operation that tunneled the ITA
pedicle through the anterior myocardium (7). The addition
of a direct anastomosis between the end of a tunneled ITA
and the side of the LAD was a logical extension of an
operation that otherwise required time to gradually maxi-
mize coronary blood flow by development of systemic to
coronary collaterals. The Cleveland Clinic investigators
became champions of routine ITA to LAD bypass, and in
1985 Lytle et al. (8) produced data convincing the broad
cardiac surgical community that the long-term patency of
the ITA bypass was superior to that of saphenous vein.
Moreover, the high ITA graft patency conveyed a substan-
tial survival advantage over saphenous vein grafts. Routine
use of ITA to LAD arterial bypass graft is now an accepted
quality indicator for CABG.
The paper by Sabik et al. (9) in this issue of the Journal
continues the long list of contributions the Cleveland Clinic
surgeons and scientists have made in confirming the added
value of routine use of ITA bypass grafting to patients with
coronary artery disease. A well-designed matched propen-
sity analysis effectively neutralizes differences in baseline
clinical characteristics that otherwise might confound ex-
tending observations from the Cleveland Clinic experience
to care decisions made for patients at other centers. In light
of prior demonstrated increase in survival associated with
routine ITA use, readers may wonder why so many matched
pairs of patients with similar baseline risk had not received
an ITA conduit at their first operation. Perhaps major
categories of information that might influence the preoper-
ative CABG plan, such as LAD size, were not consistently
available in the medical record.
As a medical student at Johns Hopkins in 1964, I was
privileged to read the first operative notes of William
Stewart Halsted, the father of modern American surgery.
His 1-page notes, often illustrated with sketches of patho-
logic specimens and operative anatomy, detailed his preop-
erative diagnosis, treatment plan, and the reason for any
change from his pre-procedure plan. His operative notes
contained sufficient detail to both validate the appropriate-
ness of any subsequent customization of pre-intraoperative
decisions and also to permit any surgical colleague to adopt
specific steps of a Halsted operative plan into their own
practice.
If the medical record information content tradition of
Halsted had been continued by the cardiac surgery profes-
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CABG procedures notes worldwide, the list of available
responses for structured reporting of reasons for use of
saphenous vein and not the ITA at time of redo CABG
might include: 1) massive bleeding associated with median
sternotomy; 2) peristernal wire from prior CABG occluding
left internal thoracic artery; 3) aortic dissection at inflow
cannulation site; 4) intramyocardial LAD; 5) ventricular
fibrillation before institution of ITA takedown; 6) damage
to ITA during takedown from chest wall; 7) patent prior
saphenous vein graft to LAD; 8) left internal thoracic artery
needed for bypass to more dominant coronary artery; and
9) other reason, specify.
Once begun, such lists could be refined to evaluate the
appropriateness of ITA use decisions based on outcome
results of intraoperative decisions and actions. The cur-
rent manuscript provides convincing evidence that use of
an ITA is reasonable in patient populations with a broad
spectrum of baseline risk and indications for a redo
CABG. However, most of the intraoperative events listed
that may have led to nonuse of an ITA are more likely to
have influenced a death outcome more than any differ-
ence in baseline characteristics.
Lack of more detail about why approximately one-third
of Cleveland Clinic patients coming to reoperation with an
intact ITA did not have an ITA conduit used during a redo
CABG operation represents a major information deficit that
cannot be replaced by modeling of preoperative data. Per-
haps some patients experienced 1 or more of the intraop-
erative complications listed previously that raised the risk of
ITA use above its expected benefit. Perhaps certain non-
emergency scenarios actually justify use of saphenous vein
grafting during elective redo CABG. Only by prospectively
acquiring medical records using structured information
describing common reasons to deviate from the preopera-
tively planned care scenarios will clinical databases grow to
include actual data that most determine the relationship of
care decisions and processes to outcomes of care delivery.
Perhaps future operative note templates will provide struc-
tured data of carefully defined reasons for deviation from
routine use of ITA in sufficient detail to establish whichintraoperative decisions optimize outcomes of cardiac sur-
gical care.
As healthcare providers migrate to use of a uniform
lexicon for describing healthcare delivery, our greatest need
is to acquire future clinical data in standardized structured
formats that facilitate provider reimbursement based on the
value the care decisions and processes bring to each indi-
vidual patient. Careful documentation of the reasons for and
outcomes of defined processes of care is itself care given.
Good care delivery is never complete until it is documented
simultaneously with creation of care information that accu-
rately documents care given with sufficient structure to
database for quality improvement of future care and as a
coherent medical record for each patient encounter.
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